i’ve been following the fortunes of bluebird biotech, or rather misfortunes, very interesting to watch, feel bad for them
Edit sorry, in reply bc chipping in on subject of medical/health investment
goes from bad to worse for them... screaming for a buyout at that sp now. the science is great but feel they have mismanaged a lot of their access strategy. a bigger player could fix this
i’ve been following the fortunes of bluebird biotech, or rather misfortunes, very interesting to watch, feel bad for them
Edit sorry, in reply bc chipping in on subject of medical/health investment